RecruitingNCT03248310

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

A Prospective Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

600 participants

Start Date

Aug 9, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

  • Patients aged 18-80 years
  • Primary and secondary lymphedema of the upper or lower extremity
  • International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema
  • Proficiency in English language

Exclusion Criteria2

  • Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm.
  • Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALQuality of Life Assessments

Upper Limb Lymphedema (ULL-27), Lymphedema Life Impact Scale, version 2 (LLISv2), LYMQOL-Leg.


Locations(3)

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activites)

Rockville Centre, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03248310


Related Trials